[{"Assets_0_Q3_USD":96690559.0,"CommonStockSharesOutstanding_0_Q3_shares":103041033.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":22320032.0,"NetIncomeLoss_1_Q3_USD":13630179.0,"NetIncomeLoss_3_Q3_USD":23945624.0,"StockholdersEquity_0_Q3_USD":77982538.0,"EarningsPerShareBasic_1_Q3_USD":0.13,"EarningsPerShareBasic_3_Q3_USD":0.23,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":102974105.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":102864571.0,"Ticker":"CPRX","CIK":"1369568","name":"CATALYST PHARMACEUTICALS, INC.","OfficialName":"Catalyst Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20190930","fy":"2019.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"872304311.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20191112"}]